Loading
A phase 3 trial of trastuzumab brengitecan, regorafenib, fruquintinib and trifluridine/tipiracil in colorectal cancer, run by Sichuan Baili Pharmaceutical Co., Ltd., not yet recruiting.
A Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Failed Prior Treatment With Oxaliplatin, Fluorouracil and Irinotecan is a phase 3, randomised interventional study registered as NCT07730489 by Sichuan Baili Pharmaceutical Co., Ltd., with a registry enrolment figure of 130 participants, started 2026-08 and due to reach its primary completion in 2027-12. Interventions recorded: BL-M07D1; Regorafenib; Fruquintinib; TAS-102. Conditions listed: Colorectal Cancer. Primary outcome: BICR-assessed Progression-free Survival (PFS). Colorectal eligibility wording from the registry: "Patients with histologically or cytologically confirmed metastatic colorectal cancer;". Sites: China. No results are recorded here; the registry entry is the source.
Shares Trifluridine/tipiracil, Regorafenib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares Trifluridine/tipiracil, Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Fruquintinib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Regorafenib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Regorafenib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Regorafenib, Anti-angiogenic therapy, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.